LIQUID PHARMACEUTICAL FORMULATIONS OF TETRAIODOTHYRONINE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15128116

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are novel formulations of oral tetraiodothyronine (T4), characterised by the formation in aqueous media of soluble, bioavailable micellar nanoaggregates.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALTERGON S AVIA DOGANA VECCHIA 2 LUGANO 6900

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
De, Rosa Mario Lugano, CH 27 193
Schiraldi, Chiara Lugano, CH 14 9

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation